⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ENTX News
Entera Bio Ltd. Ordinary Shares
BriefCast Publishes Transcript: Entera Bio's Osteoporosis KOL Roundtable on EB613 - Oral Anabolic Tablet Opportunity
globenewswire.com
ENTX
Entera Bio to Host Key Opinion Leader Webinar Highlighting the Osteoporosis Treatment Landscape and the Opportunity for EB613
globenewswire.com
ENTX
Greenberg Traurig Represents Israel-based Entera Bio in $10M Private Placement Led by BVF Partners
prnewswire.com
ENTX
Form 8-K
sec.gov
ENTX
Entera Bio Announces Pricing of $10.0 Million Direct Investment by BVF Partners with Potential for up to $24.5 Million in Total Proceeds
globenewswire.com
ENTX
Form 8-K
sec.gov
ENTXW
ENTX
Entera Bio Announces Full Year 2025 Financial Results and Provides Business Updates
globenewswire.com
ENTX
OPK
Form 8-K
sec.gov
ENTX
ENTXW
Entera Bio Submits Streamlined Phase 3 Protocol to Initiate Registrational Program for EB613 in Postmenopausal Women with Osteoporosis
globenewswire.com
ENTX
Entera Bio to Participate in the Leerink Partners 2026 Global Healthcare Conference
globenewswire.com
ENTX